Cancer Diagnosis Program Funds specimen resources and research to characterize tumors |
Radiation Research Program Funds novel radiotherapy research |
|||
Cancer Imaging Program Evaluates imaging in diagnosis, disease staging, and treatment monitoring |
Translational Research Program Integrates scientific advancements in the understanding of the biology of human cancer |
|||
Cancer Therapy Evaluation Program Assesses new anticancer agents, radiation treatments, and surgical methods |
Biometric Research Branch Provides statistical and biomathematical analyses |
|||
Developmental Therapeutics Program Funds drug discovery and development and provides related services |
Office of Cancer Complementary and Alternative Medicine Increases the quality of cancer research on complementary and alternative modalities |
The Division of Cancer Treatment and Diagnosis (DCTD) focuses its activities on developing novel diagnostics and therapies for cancer. DCTD staff members, along with colleagues throughout the National Cancer Institute (NCI), academia, and industry, are working together to generate More…
DCTD Program Accomplishments: 2008
NCI Chemical Biology Consortium (CBC)
Recovery Act Funds for Administrative Supplements
DCTD Announces Strategic Research Initiatives
Approved Oncology Drugs Now Available from DCTD in Plated Sets
Common Terminology Criteria for Adverse Events v4.0 (CTCAE) Released
An Experimental Treatment Improves Survival for Patients with Neuroblastoma
More Gene Mutations Found in Childhood Leukemia
NCI’s Clinical Trials Cooperative Groups
National Meeting Report